We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

19 May 2026 - 22 May 2026
17 Jun 2026 - 19 Jun 2026
05 Oct 2026 - 06 Oct 2026

3D Printed Implant Facilitates Endoscopic Spinal Surgery

By HospiMedica International staff writers
Posted on 27 Jul 2015
A novel spinal fusion implant printed with electron beam melt (EBM) technology aids minimally invasive endoscopic spinal surgery.

The Endoscopic Lumbar Interbody Fusion (EndoLIF) On-Cage implant is made of Ti6Al4V titanium alloy, and is characterized by a porous surface with diamond cell structure, providing an optimal base for cell proliferation and bone growth. More...
The implant is available in 30 and 35 mm lengths, and with one mm increases in the height from 8 to 14 mm. It can also be filled with autologous bone or bone substitute via two large openings, supporting the creation of a straight fusion column. Implant design allows verification of bone fusion progress by X-ray or computerized tomography (CT) imaging.

The system is intended to be used in conjunction with posterior fixation, such as via a percutaneous pedicle screw-rod system. Cage implantation can be performed with a posterior or posterolateral approach, using an open or endoscopic-assisted method via an inter-muscular approach into the intervertebral disc, similar to a mini transforaminal lumbar interbody fusion (TLIF). Since access is dura and nerve-gentle, it preserves the dorsal bony structures, thus avoiding potential scar tissue due to stepwise tissue dilation. The EndoLIF On-Cage implant is a product of joimax (Karlsruhe, Germany), and has been approved by the US Food and Drug Administration (FDA).

“With the EndoLIF program, joimax offers a complete endoscopic-assisted solution for spinal stabilization and fusion. In the future, we will be able to treat patients with even more gentle techniques,” said Wolfgang Ries, CEO and founder of joimax. “Our next development will be an EndoLIF Cage on the basis of our iLESSYS Delta system for posterior lumbar inter-body fusion (PLIF).”

Ti6Al4V is highly osseointegrative and has improved mechanical properties in comparison with pure titanium. Incorporation of foreign atoms, such as iron and oxygen are carefully observed, thereby increasing ductility (plastic deformation) and break strength is increased. Osseointegration is also enhanced by the porous structure produced when using the EBM technique in monolithic form.

Related Links:

joimax



New
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Radiofrequency Generator
GX1
New
Digital Radiography System (Ceiling Free)
Digix CF Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: In a new clinical study, the Camstent Coated Catheter was shown to reduce CAUTIs and antibiotic use compared with standard care (photo courtesy of Camstent)

Bacteria-Resistant Urinary Catheter Coating Reduces Infections and Antibiotic Use

Catheter-associated urinary tract infections (CAUTIs) are a major hospital-acquired infection, responsible for about 75% of urinary tract infections acquired in hospitals. They increase morbidity and drive... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.